Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review

Yuliya Lytvyn(University Health Network), Jensen Yeung(Sunnybrook Health Science Centre), Muskaan Sachdeva(University of Toronto), Abrahim Abduelmula(Western University), Asfandyar Mufti(University of Toronto), Khalad Maliyar(University of Toronto), Jorge R. Georgakopoulos(University of Toronto)
Pharmaceutics
November 14, 2022
Cited by 10


Related Papers